Global Hemostasis Tests (In Vitro Diagnostics) Market Analysis and Forecast Model 2018 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Hemostasis
Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model”

report has been added to ResearchAndMarkets.com’s
offering.

The increasing prevalence of surgical cases and rises in venous
thromboembolism (VTE) incidence represent major driving factors for the
hemostasis testing market. Prothrombin (PT) and Activated Prothrombin
(aPTT) tests represent the most widely used Hemostasis tests. These
devices are frequently utilized for coagulation testing prior to surgery
while D-Dimer tests tend to be performed in VTE or suspected VTE cases.

PT tests are also frequently used for monitoring of patients taking
vitamin K antagonists such as warfarin, phenprocoumon, and
acenocoumarol. Additionally, aPTT tests are used for monitoring of
patients taking unfractionated heparin, which is a commonly prescribed
anticoagulant in China and India.

Each of the covered 39 country’s color-coded and fully-sourced market
models are equipped with epidemiology based indications with procedure
volumes. To increase the data transparency, the interactive excel
deliverable covers installed base, new sales volumes, product usage,
average selling prices, market size and company share/rank analysis
(wherever available). Moreover, analyst comments with qualitative
insight offer context for quantitative data.

Scope of the Report

Key Inclusions of the Market Model

  • Insightful review of the key industry trends.
  • Annualized total Hemostasis Tests market revenue by segment and market
    outlooks from 2015-2028.
  • Granular data on total procedures, units, average selling prices and
    market values by segment.

Global, Regional, and Country-Level Market-Specific Insights

  • Qualitative market specific information is available with global
    trends further broken down into regional trends. In addition analysts
    provide unique country specific insights on the market.
  • SWOT analysis for this Hemostasis Tests market.
  • Competitive dynamics insights and trends provided for this Hemostasis
    Tests market.

Reasons to Buy

  • Develop and design your in-licensing and out-licensing strategies
    through a review of pipeline products and technologies, and by
    identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and
    driving Hemostasis Tests market.
  • Drive revenues by understanding the key trends, innovative products
    and technologies, market segments, and companies likely to impact the
    Hemostasis Tests market in the future.
  • Formulate effective sales and marketing strategies by understanding
    the competitive landscape and by analyzing the company share of market
    leaders.
  • Identify emerging players with potentially strong product portfolios
    and create effective counter-strategies to gain a competitive
    advantage.
  • Track device sales in the global and country-specific Hemostasis Tests
    market from 2015-2028.
  • Organize your sales and marketing efforts by identifying the market
    categories and segments that present maximum opportunities for
    consolidations, investments and strategic partnerships.

Companies Mentioned

  • Abbott Laboratories
  • Roche Diagnostics International Ltd
  • Siemens Healthcare GmbH
  • Diagnostica Stago SAS
  • Instrumentation Laboratory Company
  • Bio-Rad Laboratories Inc
  • bioMerieux SA
  • Quidel Corp
  • Radiometer Medical ApS
  • Tulip Diagnostics (P) Ltd

For more information about this report visit https://www.researchandmarkets.com/r/1ma0ft

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Coagulation
and Hemostasis Testing